218 related articles for article (PubMed ID: 2889354)
1. Hepatic effects of drugs used in the treatment of peptic ulcer disease.
Lewis JH
Am J Gastroenterol; 1987 Oct; 82(10):987-1003. PubMed ID: 2889354
[TBL] [Abstract][Full Text] [Related]
2. Problems associated with medical treatment of peptic ulcer disease.
Zimmerman TW
Am J Med; 1984 Nov; 77(5B):51-6. PubMed ID: 6095662
[TBL] [Abstract][Full Text] [Related]
3. [Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale].
Andersen M; Schou JS
Ugeskr Laeger; 1991 May; 153(20):1410-3. PubMed ID: 1674181
[TBL] [Abstract][Full Text] [Related]
4. Hepatotoxic and hepatoprotective potential of histamine (H2)-receptor antagonists.
Black M
Am J Med; 1987 Dec; 83(6A):68-75. PubMed ID: 2892410
[TBL] [Abstract][Full Text] [Related]
5. Possible cholestatic injury from ranitidine with a review of the literature.
Ramrakhiani S; Brunt EM; Bacon BR
Am J Gastroenterol; 1998 May; 93(5):822-6. PubMed ID: 9625136
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of H2-receptor antagonists: an overview.
Schunack W
J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
[TBL] [Abstract][Full Text] [Related]
7. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
[TBL] [Abstract][Full Text] [Related]
8. What are the differences between the H2-receptor antagonists?
Schunack W
Aliment Pharmacol Ther; 1987; 1 Suppl 1():493S-503S. PubMed ID: 2908767
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Thomson AB; Mahachai V
Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
[TBL] [Abstract][Full Text] [Related]
11. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.
Andersen M; Schou JS
Pharmacol Toxicol; 1991 Oct; 69(4):253-8. PubMed ID: 1683484
[TBL] [Abstract][Full Text] [Related]
12. Safety profile of H2-receptor antagonists: current status of famotidine.
Levine JB
J Int Med Res; 1989; 17 Suppl 1():48A-53A. PubMed ID: 2566543
[TBL] [Abstract][Full Text] [Related]
13. Effects of H2 receptor antagonists on the hepatotoxicity of various chemicals.
Leonard TB; Dent JG
Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):375-88. PubMed ID: 6147001
[TBL] [Abstract][Full Text] [Related]
14. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
[TBL] [Abstract][Full Text] [Related]
15. Actions of cimetidine and ranitidine at some cholinergic sites: implications in toxicology and anesthesia.
Gwee MC; Cheah LS
Life Sci; 1986 Aug; 39(5):383-8. PubMed ID: 2874464
[TBL] [Abstract][Full Text] [Related]
16. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of H2-receptor antagonists.
Iberti TJ
DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
[TBL] [Abstract][Full Text] [Related]
18. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
19. Adverse reactions and interactions with H2-receptor antagonists.
Penston J; Wormsley KG
Med Toxicol; 1986; 1(3):192-216. PubMed ID: 2878343
[TBL] [Abstract][Full Text] [Related]
20. Haematological adverse effects of histamine H2-receptor antagonists.
Aymard JP; Aymard B; Netter P; Bannwarth B; Trechot P; Streiff F
Med Toxicol Adverse Drug Exp; 1988; 3(6):430-48. PubMed ID: 2905759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
